No changes in anti-JCV antibody status after Natalizumab discontinuation in a large population of Multiple Sclerosis patients

被引：0
|
作者：
Sgarlata, E. [1 ,2 ]
Chisari, C. G. [3 ]
D'Amico, E. [3 ]
Toscano, S. [3 ]
Zanghi, A. [3 ]
Lo Fermo, S. [3 ]
Patti, F. [3 ]
机构：
[1] Sapienza Univ, Dept Human Neurosci, Rome, Italy
[2] Umberto I Hosp, Dept Med, Siracusa, Italy
[3] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P658
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [41] Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration
    Shinji Aoyama
    Masahiro Mori
    Akiyuki Uzawa
    Tomohiko Uchida
    Hiroki Masuda
    Ryohei Ohtani
    Satoshi Kuwabara
    Journal of Neurology, 2018, 265 : 1145 - 1150
  • [42] Stability of anti-JCV antibody index in multiple sclerosis: a 6-year longitudinal study
    Hegen, H.
    Auer, M.
    Bsteh, G.
    Di Pauli, F.
    Deisenhammer, F.
    Berger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 582 - 582
  • [43] Natalizumab Risk Stratification: Role of a Two- Step Anti-JCV Antibody Assay
    O'Connor, Paul W.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (05) : 670 - 675
  • [44] Stability of Anti-JCV Antibody Index in Multiple Sclerosis: A 6-Year Longitudinal Study
    Hegen, Harald
    Auer, Michael
    Bsteh, Gabriel
    Di Pauli, Franziska
    Deisenhammer, Florian
    Berger, Thomas
    NEUROLOGY, 2016, 86
  • [45] Prevalence of anti-JCV antibodies in a multi-national cohort of multiple sclerosis patients
    Olsson, T.
    Achiron, A.
    Alfredsson, L.
    Chan, A.
    Comi, G.
    Hillert, J.
    Moiola, L.
    Oturai, A.
    Sorensen, P.
    Potts, J.
    Hotermans, C.
    Plavina, T.
    Paes, D.
    Subramanyam, M.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S134 - S135
  • [46] Tonsillectomy and Negative JCV Antibody Status in Multiple Sclerosis Patients
    Avila, Mirla
    Trevino, Sorleen
    Thakolwiboon, Smathorn
    Suady, Suhaireirene
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 158 - 158
  • [47] JCV detection in multiple sclerosis patients treated with natalizumab
    Saud A. Sadiq
    Lauren M. Puccio
    Edward W. A. Brydon
    Journal of Neurology, 2010, 257 : 954 - 958
  • [48] JCV detection in multiple sclerosis patients treated with natalizumab
    Sadiq, Saud A.
    Puccio, Lauren M.
    Brydon, Edward W. A.
    JOURNAL OF NEUROLOGY, 2010, 257 (06) : 954 - 958
  • [49] StratifyJCV Serum anti-JCV antibody assay for patients treated with natalizumab: quality control of sample analysis by Unilabs
    Svendsen, Sofie
    Skovgaard, Tine
    Carstensen, Kristine
    Drenth, Annemarie
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 978 - 979
  • [50] Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis
    Hegen, Harald
    Walde, Janette
    Bsteh, Gabriel
    Auer, Michael
    Wurth, Sebastian
    Zinganell, Anne
    Di Pauli, Franziska
    Deisenhammer, Florian
    Berger, Thomas
    FRONTIERS IN IMMUNOLOGY, 2018, 9
12345